MAR 25, 2019 10:09 AM PDT

Automated Drug Delivery System To Treat Post-Bariatric Hypoglycemia

WRITTEN BY: Nouran Amin

Low blood sugar is an increasing complication of patients who undergone weight-loss surgery known as post-bariatric hypoglycemia (PBH). The condition is characterized by a severe and debilitating low blood sugars after meals and if left untreated can result in seizures, loss of consciousness and death.

Learn more about gastric bypass complications:

Now, new research has developed an automated drug delivery system that can combat and prevent dangerously low blood sugar in weight-loss surgical patients. The research was presented at the 2019 Endocrine Society's annual meeting.

"Currently available treatments are not always effective for severely affected patients," said lead researcher Christopher M. Mulla, M.D. of Joslin Diabetes Center in Boston, Mass.

The automated drug delivery system is similar to an insulin pump and can detect decreasing glucose levels. They system will then deliver the hormone glucagon when levels are low to prevent hypoglycemic events.

"This study demonstrated that our glucagon automated delivery system can detect imminent low blood sugar and deliver a small dose of glucagon, yielding improvements in blood glucose levels after meals and reducing severe hypoglycemia in patients with PBH," Mulla said. "Further research and development of this system will help treat this challenging disease."

Source: Endocrine Society

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 17, 2019
Cardiology
NOV 17, 2019
Somethings Fishy With Omega 3 Claims
Each month nearly 20 million Americans turn to fish oil for heart disease prevention. Though it may sound healthy, this trend is troubling in the face of z...
NOV 17, 2019
Drug Discovery & Development
NOV 17, 2019
Standard Treatment Resistance Discovered in Crohn's Disease
Researchers have mapped out more than 100,000 immune cells from biopsy samples of patients with Crohn's disease. The biopsy samples were retrieved from...
NOV 17, 2019
Infographics
NOV 17, 2019
Surface Plasmon Resonance (SPR) Technology
Surface plasmon resonance (SPR) allows researchers to investigate different types of biomolecular interactions and mechanisms in real-time and label-free....
NOV 17, 2019
Genetics & Genomics
NOV 17, 2019
Gene-Editing Breakthrough for Cervical Cancer
Researchers at the The Menzies Health Institute Queensland have found a way to use gene therapy CRISPR-Cas9 to treat cervical cancer. The first treatment o...
NOV 17, 2019
Drug Discovery & Development
NOV 17, 2019
Diabetes: The next-generation therapy
A publication in Nature Communications describes a therapeutic that can avoid the side-effects of insulin in diabetic treatments particularly hypoglycemia....
NOV 17, 2019
Genetics & Genomics
NOV 17, 2019
New Way to Determine What Our Genes Do
Geneticists at the University of Virginia (UVA) School of Medicine have developed a new way to determine what our genes do. This will not only allow scient...
Loading Comments...